Stephen K Doberstein

CIK 1480111 · SVP & Chief Scientific Officer · last filed 2026-06-02

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$6.39M

Companies

3

Total Filings

42

Lifetime Open-Market Net

-$30.48M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
FBRX Director $17.56 $0 6 2026-06-02
Dicerna Pharmaceuticals Inc (DRNA) Delisted Director 0 $38.22 $0 $0 4 2021-12-29
NKTR SVP & Chief Scientific Officer 107,668 $59.38 $6.39M -$30.48M 32 2019-09-09

Recent Filings · Page 3 of 5

42 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2017-12-19 NKTR Grant (A) +26,000 $0 EDGAR
2017-11-17 NKTR Mixed +12,718 -$211.5K EDGAR
2017-11-08 NKTR Mixed -$7.72M EDGAR
2017-10-10 NKTR Mixed -$674.4K EDGAR
2017-08-18 NKTR Sell (S) −1,701 -$32.9K EDGAR
2017-05-18 NKTR Sell (S) −1,701 -$33.3K EDGAR
2017-04-07 NKTR Mixed -$1.22M EDGAR
2017-02-17 NKTR Sell (S) −1,261 -$16.6K EDGAR
2016-12-15 NKTR Grant (A) +17,500 $0 EDGAR
2016-11-18 NKTR Sell (S) −670 -$9.4K EDGAR
Showing 2130 of 42
Page 3 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.